Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-022022
Filing Date
2014-05-16
Accepted
2014-05-16 17:42:10
Documents
1
Period of Report
2014-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7582
  Complete submission text file 0001140361-14-022022.txt   9055
Mailing Address 660 MADISON AVENUE SUITE 1700 NEW YORK NY 10065
Business Address 660 MADISON AVENUE SUITE 1700 NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 OFFICE CENTER DRIVE SUITE 400 FT. WASHINGTON PA 19034
Business Address
Marshall Joseph W III (Reporting) CIK: 0001458584 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23047 | Film No.: 14852693